Disease Markers / 2019 / Article / Tab 2

Research Article

Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer

Table 2

The comparative analysis on the mean of molecular indexes and different sample collection time groups.

GroupPreoperationPostoperationPostradiochemotherapy value (preoperation vs. postoperation) value (preoperation vs. postradiochemotherapy) value (postoperation vs. postradiochemotherapy)

Mutation number5 (4.71)4 (4.62)2.5 (3.15)0.47750.0230.313
Mutation frequency2.99 (7.01)2.6 (8.24)1.85 (2.68)0.64310.2850.067

Median ().

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.